Nvidia acquires Kumo AI and partners with Abridge on a healthcare model

The Kumo AI acquisition deepens Nvidia's push beyond silicon into enterprise software and vertical AI applications. Kumo specializes in predictive AI over business/relational data, and the deal continues a buying spree that includes Run:ai (~$700M), Illumex, and a Groq agreement — a clear strategy to own more of the AI stack above the GPU.

The Abridge partnership targets healthcare: Nvidia is co-developing an AI model with the ambient-listening startup, applying its compute and tooling to clinical documentation and medical reasoning. Separately, Nvidia launched an AI factory manager blueprint for autonomous manufacturing, extending its industrial/robotics ambitions.

Competitively, the moves position Nvidia as more than an arms dealer — increasingly a platform and applications company — even as Microsoft-backed challenger D-Matrix and others contest its inference-hardware lead. Healthcare AI also drew ethics concerns this week, with practitioners warning that models weighting peer-reviewed research equally with anecdotal forum data could be clinically dangerous, a caveat that will shadow any Nvidia-Abridge clinical deployment.